Endovascular Intervention Versus Surgery in Ruptured Intracranial Aneurysms in Equipoise

Author:

Chai Chung Liang12ORCID,Pyeong Jeon Jin345,Tsai Yi-Hsin6,Whittaker Paula1,Macdonald R. Loch7,Lindgren Antti E.8,Ayling Oliver G.S.9,Acioly Marcus André1011,Cohen-Gadol Aaron12,Huang Yu-Hua

Affiliation:

1. From the School of Health Sciences, Faculty of Biology Medicine and Health, The University of Manchester, United Kingdom (C.L.C., P.W.)

2. Department of Neurosurgery, Yee Zen General Hospital, Taoyuan, Taiwan (C.L.C.)

3. Institute of New Frontier Stroke Research, Chuncheon, Republic of Korea (J.P.J.)

4. Department of Neurosurgery, Hallym University College of Medicine, Chuncheon, Republic of Korea (J.P.J.)

5. Genetic and Research Incorporation, Chuncheon, Republic of Korea (J.P.J.)

6. Neurointensive Care Unit, Division of Neurosurgery, Department of Surgery, Far Eastern Memorial Hospital, New Taipei City, Taiwan (Y.-H.T.)

7. Division of Neurosurgery, Department of Surgery, St. Michael’s Hospital, University of Toronto, ON, Canada (R.L.M.)

8. Department of Neurosurgery, Kuopio University Hospital, Kuopio, Finland (A.E.L.)

9. Division of Neurosurgery, The University of British Columbia, Vancouver, Canada (O.G.S.A.)

10. Universidade Federal Fluminense, Division of Neurosurgery, Rio de Janeiro, Brazil (M.A.A.)

11. Universidade Federal do Rio de Janeiro, Brazil (M.A.A.)

12. Department of Neurological Surgery, Indiana University School of Medicine and Goodman Campbell Brain and Spine, Indianapolis (A.C.-G.)

Abstract

Background and Purpose— The benefits of endovascular intervention over surgery in the treatment of ruptured aneurysms of anterior circulation remains uncertain. Recently, published studies did not find superiority of endovascular intervention, challenging earlier evidence from a clinical trial. The earlier evidence also had a higher than average proportion of patients in good clinical status, leading to uncertainty about external validity of earlier trials. Methods— We performed a systematic review of studies after 2005 under a protocol published in the International Prospective Register of Systematic Reviews. Primary outcomes were posttreatment rebleeding and adverse events (procedural complications). Secondary outcomes were dependency at 3 to 6 and 12 months, delayed cerebral ischemia, and seizures. Results— Rebleeding was more frequent after endovascular intervention (Peto OR, 2.18 [95% CI, 1.29–3.70]; 3104 participants; 15 studies; I 2 =0%, Grading of Recommendations, Assessment, Development and Evaluation: very low certainty of evidence). Fewer adverse events were reported with the endovascular intervention (RR, 0.71 [95% CI, 0.53–0.95]; 1661 participants; 11 studies; I 2 =14%, Grading of Recommendations, Assessment, Development and Evaluation: low certainty of evidence). Three to six months dependency (RR, 0.82 [95% CI, 0.73–0.93]; 4081 participants; 18 studies; I 2 =15%, Grading of Recommendations, Assessment, Development and Evaluation: low certainty of evidence) and 12-month dependency (RR, 0.76 [95% CI, 0.66–0.86]; 1981 participants; 10 studies; I 2 =0%, Grading of Recommendations, Assessment, Development and Evaluation: low certainty of evidence) were lower after endovascular intervention. Conclusions— This study found consistent results between recent studies and the earlier evidence, in that endovascular intervention results in lower chance of dependency compared with surgery for repair of ruptured anterior circulation aneurysms. A lower proportion of patients in good clinical status in this review supports the application of the earlier evidence. Registration— URL: https://www.crd.york.ac.uk/PROSPERO . Unique identifier: CRD42018090396.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3